Immune remodeling during cervical cancer chemoradiotherapy: temporal biomarkers and the timing of checkpoint blockade
Chenguang Yang, Xuan Song, Hongmei Sun, Min Chen, Xialing Zhu · 2026
Read Immune remodeling during cervical cancer chemoradiotherapy: temporal biomarkers and the timing of checkpoint blockade by Chenguang Yang, Xuan Song, Hongmei Sun, Min Chen, Xialing Zhu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13582198.txt.
Description
Chenguang Yang and four colleagues retell cervical cancer immunotherapy along the treatment timeline, in a review published in two thousand twenty-six. Chemoradiation is curative backbone therapy, and checkpoint drugs have joined it with contradictory trial results. One major trial improved survival; another did not.
Older reviews sorted the tumor's immune environment by cell type using single pre-treatment snapshots. This one organizes serial sampling before, during, and after treatment. Four sequential states emerge, from a virus-shaped baseline through an early priming window driven by DNA damage sensing. The divergence between trials may be a timing problem: the same drug helps or not depending on the immune state it lands in. Scheduling, not selection, is the hypothesis.
Catalog record
| CREATOR | Chenguang Yang, Xuan Song, Hongmei Sun, Min Chen, Xialing Zhu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 100 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |